| scholarly article | Q13442814 |
| P2093 | author name string | Harry A Drabkin | |
| Joëlle Roche | |||
| Patrick Nasarre | |||
| Bruno Constantin | |||
| Nicolas Bourmeyster | |||
| Thomas Harnois | |||
| Guy Raymond | |||
| Lydie Rouhaud | |||
| P2860 | cites work | Neuropilin is a receptor for the axonal chemorepellent Semaphorin III | Q24310596 |
| Neuropilin is a semaphorin III receptor | Q24310629 | ||
| Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns | Q24311901 | ||
| Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer | Q24319164 | ||
| Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor | Q24321564 | ||
| Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B | Q24555083 | ||
| Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration | Q24681536 | ||
| Rho GTPases and the actin cytoskeleton | Q27860579 | ||
| Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III | Q28114812 | ||
| Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee | Q28137621 | ||
| Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1 | Q28140309 | ||
| Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected] | Q28140705 | ||
| Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules | Q28142248 | ||
| Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors | Q28145862 | ||
| Molecular basis of semaphorin-mediated axon guidance | Q28611466 | ||
| Distribution of semaphorin IV in adult human brain | Q33856398 | ||
| Functions of semaphorins in axon guidance and neuronal regeneration | Q33956198 | ||
| Signalling by semaphorin receptors: cell guidance and beyond. | Q33994985 | ||
| Semaphorin-mediated axonal guidance via Rho-related G proteins. | Q34090171 | ||
| Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. | Q34091667 | ||
| Antagonistic effects of Rnd1 and RhoD GTPases regulate receptor activity in Semaphorin 3A-induced cytoskeletal collapse. | Q34108858 | ||
| Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line | Q34111043 | ||
| Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones | Q34357496 | ||
| Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin | Q34382506 | ||
| Knowing how to navigate: mechanisms of semaphorin signaling in the nervous system | Q34528240 | ||
| Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. | Q36382096 | ||
| Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts | Q38310846 | ||
| Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase | Q38330900 | ||
| Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice | Q40735367 | ||
| Differential responsiveness to the chemorepellent Semaphorin 3A distinguishes Ipsi- and contralaterally projecting axons in the chick midbrain | Q40782020 | ||
| Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. | Q40804521 | ||
| Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation | Q40881030 | ||
| An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo | Q41145880 | ||
| Semaphorin III is needed for normal patterning and growth of nerves, bones and heart | Q41159467 | ||
| Phosphorylation of cofilin by LIM-kinase is necessary for semaphorin 3A-induced growth cone collapse. | Q45345107 | ||
| Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection. | Q52192538 | ||
| A mechanism for modulation of cellular responses to VEGF: activation of the integrins | Q64380279 | ||
| Inhibition of cell motility after nm23 transfection of human and murine tumor cells | Q70679705 | ||
| Localized collapsing cues can steer growth cones without inducing their full collapse | Q72549760 | ||
| Semaphorin III can induce death in sensory neurons | Q73250608 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 83-92 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading | |
| P478 | volume | 5 |
| Q28389391 | A review of the past, present, and future directions of neoplasia |
| Q36378850 | Altered gene expression in early postnatal monoamine oxidase A knockout mice |
| Q35866684 | Application of Gene Expression Trajectories Initiated from ErbB Receptor Activation Highlights the Dynamics of Divergent Promoter Usage |
| Q34576220 | Caveolin-1 regulates Rac1 activation and rat pulmonary microvascular endothelial hyperpermeability induced by TNF-α. |
| Q36138195 | Class 3 semaphorin signaling: the end of a dogma |
| Q28389985 | Coming of Age in the Life of |
| Q27027713 | Control of cellular motility by neuropilin-mediated physical interactions |
| Q33306610 | Differentially expressed genes in embryonic cardiac tissues of mice lacking Folr1 gene activity |
| Q48871149 | Dlx1 transcription factor regulates dendritic growth and postsynaptic differentiation through inhibition of neuropilin-2 and PAK3 expression |
| Q33823772 | Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype |
| Q37484796 | Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues |
| Q46035783 | Fragile X mental retardation protein recognition of G quadruplex structure per se is sufficient for high affinity binding to RNA. |
| Q28506945 | Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance |
| Q37077487 | High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer |
| Q33647661 | Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer |
| Q33203897 | Identification of genes differentially expressed in rat alveolar type I cells |
| Q55333468 | Impact of semaphorin expression on prognostic characteristics in breast cancer. |
| Q34762113 | Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction. |
| Q42121924 | Molecular and clinical aspects of targeting the VEGF pathway in tumors. |
| Q33853031 | Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes. |
| Q39783663 | Neuropilin-2 acts as a modulator of Sema3A-dependent glioma cell migration |
| Q38161356 | Neuropilins: a new target for cancer therapy |
| Q37475741 | Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. |
| Q21129485 | Receptor complexes for each of the Class 3 Semaphorins |
| Q41773333 | Recombinant bacterial expression and purification of human fragile X mental retardation protein isoform 1. |
| Q24550871 | Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells |
| Q41491009 | Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program. |
| Q24564247 | Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect |
| Q41985319 | Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression. |
| Q24562741 | Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype |
| Q34768320 | Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion |
| Q37426239 | Semaphorin signals on the road to cancer invasion and metastasis |
| Q34637615 | Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis |
| Q38807200 | Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation |
| Q37072227 | Semaphorins and their receptors in lung cancer. |
| Q35658200 | Semaphorins in angiogenesis and tumor progression |
| Q33372124 | Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells |
| Q36928030 | Targeting endothelial and tumor cells with semaphorins |
| Q37027655 | The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation |
| Q36193422 | The brain within the tumor: new roles for axon guidance molecules in cancers. |
| Q46411138 | The cellular and molecular basis of axonal growth |
| Q38256958 | The emerging role of class-3 semaphorins and their neuropilin receptors in oncology |
| Q39137754 | The role of axon guidance factor semaphorin 6B in the invasion and metastasis of gastric cancer |
| Q38929961 | The role of the semaphorins in cancer |
| Q35012897 | The semaphorins |
| Q37200576 | The semaphorins: versatile regulators of tumour progression and tumour angiogenesis |
| Q36808641 | Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. |
Search more.